Merus Labs International Stock Price (NASDAQ:MSLI)

Add to My Stocks
$1.3 $0 (0%) MSLI stock closing price Jul 17, 2017 (Closing)
Prev Close* : $1.3
Market Cap:
$152.56M
Day Low: $1.29
52 Week Low: $0.70
Open: $1.3
Volume: -
Day High: $1.3
52 Week High: $1.33
Dividend:
0.00

Latest Stock Market News

Latest Articles

Merus Labs International News - From Partners

Merus Labs Announces Record Q1 2015 Results   by Marketwired on Feb 11, 2015
Merus Labs Announces Management & Board Changes   by Marketwired on Sep 23, 2014

MSLI Stockcharts

View MSLI PE ratio, PS ratio stocks charts and compare with peers.
MSLI Chart
Note: Compare Merus Labs International stock price history with the index and industry peers.

Merus Labs International Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
1.92
PB ratio (
price to book ratio
)
1.04

Merus Labs International Returns

ROE
(return on equity)
-7%

Merus Labs International Financial Ratios

Asset Turnover
0.26
Receivables Turnover
4.1
Debt to Equity
0.66
Dividend Yield
0%

MSLI Industry Peers

Company Price Change (%)
Immune Design (IMDZ)3.20.05 (1.54%)
Dragon Jade International (DGJI)2.80 (0%)
Eisai (ESALY)95.832.74 (2.94%)
Merck (MRK)70.420 (0%)
Glaxosmithkline (GSK)39.630.42 (1.07%)
Eli Lilly (LLY)106.881.17 (1.11%)
Raptor Pharma (RPTP)90 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Merus Labs International Inc (USA) Stock News - Partner Headlines

Merus Labs International Financial Statements

income statement20162015201420132012
Net Sales or Revenues68.78M39.97M24.17M27.97M10.34M
Net Income-7.14M-0.19M-7.45M-3.05M-20.56M
Total Operating Expense45.9M28.75M20.84M18.54M9.58M
View Merus Labs International income statement
balance sheet20162015201420132012
Total Assets283.49M215.56M183.22M85.76M91.7M
Total Liabilities134.13M67.92M77.24M42.49M56.69M
Shareholders Equity149.35M147.63M105.98M43.27M35M
View Merus Labs International balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-8.81M-8.52M-1.32M--2.06M
Net Cash from (used by) Operating Activities16.67M16.61M11.79M12.3M1.75M
Increase (Decrease) in Prop Plant And Equipment-0.17M--0.11M-0.01M-
View Merus Labs International cash flow statement

Merus Labs International Stock Message Board

Merus Labs International stock price ended the last trading day at $1.3. The total market value as denoted by $152.56M for Merus Labs International, is the market value of the company's outstanding shares. Merus Labs International valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Merus Labs International stock price and Merus Labs International share price mean the same thing. The volume of shares traded stood at 9,409 on the last trading day, as is evident from Merus Labs International stock chart, and MSLI stock quote data. Merus Labs International paid 0.00 stock dividends to its shareholders during last quarter. Merus Labs International stock price history, gives the entire historical data for MSLI stock.